NPS PHARMACEUTICALS INC: cashflow_investing

Value{"amount": -5129000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2010-01-01 – 2010-09-30
Statuscurrent
EntityNPS PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001136261-11-000570 · Open the official SEC filing →
Retrieved: 2026-08-19T08:56:45.347475+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000890465/cashflow-investing/2010-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/5af8e5de-d1f3-4e72-b2e4-68937e8391ce

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies